Gene · 3914
Papers1,750
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,750
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Full-length transcriptome analysis of papillary thyroid carcinoma reveals correlation between LAMB3 expression and clinical features. | BMC Cancer | 2025 | 41139196 | PubTator, text mining | PubMed |
| Bioinformatics analysis to investigate the genetic associations between diabetes and pancreatic cancer. | Aging Male | 2025 | 41099341 | PubTator, text mining | PubMed |
| NGS Approaches in Clinical Diagnostics: From Workflow to Disease-Specific Applications. | Int J Mol Sci | 2025 | 41096862 | PubTator, text mining | PubMed |
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol. | PLoS One | 2025 | 40971360 | PubTator, text mining | PubMed |
| Identifying novel genetic variants in epidermolysis Bullosa among Middle Eastern Arab Families: Insights from whole exome sequencing and computational analysis. | PLoS One | 2025 | 40956805 | PubTator, text mining | PubMed |
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis. | Br J Cancer | 2025 | 40931129 | PubTator, text mining | PubMed |
| Gene expression signature of IKZF1 deleted B-cell acute lymphoblastic leukaemia reveals a unique regulation of MUC4. | Br J Haematol | 2025 | 40878232 | PubTator, text mining | PubMed |
| Genomic landscapes of breast cancer in African populations: a systematic review. | NPJ Breast Cancer | 2025 | 40813389 | PubTator, text mining | PubMed |
| Junctional Epidermolysis Bullosa Caused by a Hemiallelic Nonsense Mutation in LAMA3 Revealed by 18q11.2 Microdeletion. | Int J Mol Sci | 2025 | 40806473 | PubTator, text mining | PubMed |
| ALDH18A1 has carcinogenic functions and regulates alternative splicing events of DNA repair-related genes in esophageal carcinoma cells. | Sci Rep | 2025 | 40770266 | PubTator, text mining | PubMed |
| Genetic Screening of a Nonsyndromic Amelogenesis Imperfecta Patient Cohort Using a Custom smMIP Reagent for Selective Enrichment of Target Loci. | Hum Mutat | 2025 | 40741335 | PubTator, text mining | PubMed |
| Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases. | J Neurooncol | 2025 | 40731085 | PubTator, text mining | PubMed |
| Genetic profiling of epidermolysis bullosa in a large Brazilian cohort. | Clin Exp Dermatol | 2025 | 40701620 | PubTator, text mining | PubMed |
| An extracellular matrix niche secreted by epithelial cells drives intestinal organoid formation. | Dev Cell | 2025 | 40680738 | PubTator, text mining | PubMed |
| Clinical and Allelic Heterogeneity in a Small Cohort of Patients with Inherited Epidermolysis Bullosa. | Int J Mol Sci | 2025 | 40565224 | PubTator, text mining | PubMed |
| NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4-acetylated LAMB3-mediated FAK/ERK pathway. | Cancer Commun (Lond) | 2025 | 40540648 | PubTator, text mining | PubMed |
| Skin microbiome analysis of a junctional epidermolysis bullosa patient treated with genetically modified stem cells. | J Dtsch Dermatol Ges | 2025 | 40509691 | PubTator, text mining | PubMed |
| The Spectrum of Epidermolysis Bullosa in KwaZulu-Natal, South Africa. | Int J Dermatol | 2025 | 40369731 | PubTator, text mining | PubMed |
| MYOSLID: A Critical Modulator of Cancer Hallmarks. | Genes (Basel) | 2025 | 40149492 | PubTator, text mining | PubMed |
| EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer. | Mol Cancer | 2025 | 40121428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3914/papers?page=3